Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
44.76
-1.42 (-3.07%)
Jun 1, 2026, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $55 | Hold | Maintains | $55 | +22.88% | May 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $66 | Buy | Reiterates | $66 | +47.45% | May 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $65 | Buy | Maintains | $65 | +45.22% | May 6, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $60 → $65 | Buy | Maintains | $60 → $65 | +45.22% | Mar 24, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $65 | Buy | Maintains | $65 | +45.22% | Feb 25, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $63 | Buy | Maintains | $63 | +40.75% | Feb 24, 2026 |